Microfluidic Electrophoretic Assay for Multiplexed Biomarker Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Confirmatory diagnostics for infectious diseases like HCV and HIV are limited by high resource consumption, labor intensity, and the need for centralized laboratories, making point-of-care confirmation challenging, especially in resource-constrained settings.

Innovation Solution

A microfluidic device with an elongated flow path and polymeric medium containing immobilized capture members for specific analytes, utilizing directional electric fields for sample analysis, enabling rapid and sensitive detection of multiple biomarkers.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional confirmatory blotting assays are used, then high sensitivity and specificity are achieved, but the assays are slow, labor intensive, and costly requiring centralized laboratories

Engineering Contradiction:
Improvediagnostic sensitivity and specificityVSAvoidassay speed and resource efficiency
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The device segments the confirmatory assay into two independent microfluidic channels: a first channel for detecting first biomarkers and a second channel for detecting second biomarkers. Each channel contains immobilized capture members that specifically bind to target biomarkers, allowing parallel processing of multiple analytes simultaneously. This segmentation enables the assay to be performed in a single laboratory setting without requiring centralized facilities, while maintaining the sensitivity and specificity of conventional blotting assays.

Inventive Principle:
Principle #1Segmentation

2Measurement precision

If conventional confirmatory assays are performed, then accurate biomarker detection is achieved, but high resource consumption and labor intensity are required

Engineering Contradiction:
Improvebiomarker detection accuracyVSAvoidlabor and infrastructure requirements
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention merges multiple assay functions into a single integrated microfluidic device. Both biomarker detection channels are incorporated into one device with shared fluidic components, including a common sample inlet and buffer reservoirs. This merging reduces the overall complexity compared to performing separate blotting assays, eliminates the need for multiple separate laboratory setups, and reduces labor requirements while maintaining detection accuracy through the specific binding of capture members to target biomarkers.

Inventive Principle:
Principle #5Merging (Combining)

3Measurement precision

If centralized laboratory processing is used, then confirmatory diagnostic accuracy is maintained, but accessibility in resource-constrained settings is limited

Engineering Contradiction:
Improveconfirmatory diagnostic accuracyVSAvoidpoint-of-care accessibility
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The microfluidic device is designed for self-service operation with automated fluid handling through electrophoretic pumping. The device contains integrated buffer reservoirs that automatically provide washing and blocking buffers during the assay process, eliminating the need for manual intervention at each step. The electrophoretic pumping system automatically moves samples and reagents through the channels based on applied voltage, requiring minimal operator training. This self-service capability enables the device to be operated in resource-constrained settings without requiring specialized laboratory infrastructure or highly trained personnel, while maintaining diagnostic accuracy through the specific capture member-biomarker binding.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The microfluidic device facilitates rapid, sensitive, and multiplexed detection of biomarkers, reducing assay time from hours to minutes, and improving accessibility for point-of-care diagnostics, comparable to conventional methods in sensitivity and specificity.

Implementation Method 1

applying a directional electric field to the elongated flow path in a manner sufficient to move components through the polymeric medium

Methodology Applied
Scientific EffectElectrophoresis: Electrophoresis

Data Source

PatentUS20240353403A1Electrophoretic Bar Code Assay Devices and Methods for Making and Using the Same
Publication Date: 2024.10.24 RGT UNIV OF CALIFORNIA
  • US20240353403A1 patent drawing
  • US20240353403A1 patent drawing
  • US20240353403A1 patent drawing

AI summary

A microfluidic device for determining whether an analyte is present in a sample is provided. The microfluidic device includes an elongated flow path having a polymeric medium, where the polymeric medium includes a first analyte detection domain having a first immobilized capture member that specifically binds to a first analyte and a second analyte detection domain having a second immobilized capture member that specifically binds to a second analyte. Also provided are methods, systems and kits in which the subject microfluidic devices find use, as well as methods of producing the same.